IP Library Granted Patent US 10,480,003
Granted Patent B2
US 10,480,003 · App. 15/230,332 · Granted Nov 19, 2019

Constructs and systems and methods for engineering a CO

Inventors: Cheryl A. Kerfeld (Walnut Creek, CA); Patrick Shih (Berkeley, CA); Jan Zarzycki (Marburg, DE); Krishna K. Niyogi (Oakland, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
C12N15/8269C12N15/8243Y02P60/247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,480,003
App. No.
15/230,332
Granted
Nov 19, 2019
Kind
B2
Abstract

Methods and compositions to introduce a synthetic pathway based on the 3-hydroxypropionate bicycle into an organism such as the model cyanobacterium, Synechococcus elongatus sp. PCC 7942. The heterologously expressed pathway acts as a photorespiratory bypass as well as an additional carbon fixation cycle orthogonal to the endogenous Calvin-Benson cycle. We demonstrate the function of all six introduced enzymes, which not only has implications on increasing net-photosynthetic productivity, but also key enzymes in the pathway are involved in high-value products that are of biotechnological interest, such as 3-hydroxypropionate.

Claims (20)

1. A recombinant host cell comprising heterologously expressed genes mcr, mcl, mch, mct, meh, and pcs, and a second heterologously expressed mct gene, and wherein the recombinant host cell does not naturally express the heterologously expressed genes and wherein the host cell produces a synthetic photorespiratory bypass pathway.

2. The recombinant host cell of claim 1 , wherein at least one of the heterologously expressed genes is from Chloroflexus aurantiacus J-10-fl.

3. The recombinant host cell of claim 1 , wherein at least one of the heterologously expressed genes is from Erythrobacter sp. NAP1.

4. The recombinant host cell of claim 1 , wherein the heterologously expressed genes comprise genes having a sequence of SEQ ID NOs: 19-24 or functional homologs thereof.

5. The recombinant host cell of claim 4 , wherein the functional homologs comprise genes having a sequence of SEQ ID NOs: 25-30.

6. The recombinant host cell of claim 1 , wherein the second heterologous mct gene is from the same organism as the mct gene.

7. The recombinant host cell of claim 1 , wherein the second heterologous mct gene is from a different organism than the mct gene.

8. The recombinant host cell of claim 1 , wherein one or more of the heterologously expressed genes is encoded from a DNA expression cassette.

9. The recombinant host cell of claim 8 , wherein the DNA expression cassette comprises a promoter operably linked to the one or more heterologously expressed genes.

10. The recombinant host cell of claim 8 , wherein the expression cassette has a sequence in accordance with any of SEQ ID NOs: 31-34.

11. The recombinant host cell of claim 8 , wherein the expression cassette comprises a selectable marker.

12. The recombinant host cell of claim 8 wherein the expression cassette comprises an inducible promoter.

13. The recombinant host cell of claim 12 wherein the inducible promoter is an IPTG-inducible promoter.

14. The recombinant host cell of claim 1 , wherein the heterologously expressed genes are stably incorporated into the recombinant host cell.

15. The recombinant host cell of claim 1 , wherein the heterologously expressed genes are stably incorporated into the genome of the recombinant host cell.

16. The recombinant host cell of claim 1 , wherein the heterologously expressed genes are transiently expressed from a plasmid.

17. The recombinant host cell of claim 1 , wherein the recombinant host cell is a bacterial cell, a cyanobacterial cell, an oxygenic photoautotroph or a plant cell.

18. A recombinant host cell comprising stably transformed heterologous genes having sequences of SEQ ID Nos: 19-24 or functional homologs thereof wherein SEQ ID No: 23 encodes a first heterologously expressed mct gene, and wherein the recombinant host cell comprises a second heterologously expressed mct gene, wherein the host cell produces a synthetic photorespiratory bypass pathway.

19. The recombinant host cell of claim 18 , wherein the recombinant host cell is a bacterial cell, a cyanobacterial cell, an oxygenic photoautotroph or a plant cell.

20. The recombinant host cell of claim 18 , wherein the functional homologs comprise genes having a sequence of SEQ ID NOs: 25-30.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2017
From: KERFELD, CHERYL A.; SHIH, PATRICK; ZARZYCKI, JAN; NIYOGI, KRISHNA K.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 040993/0467 →
CONFIRMATORY LICENSE Recorded Nov 18, 2016
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 040703/0673 →
Continuity (3)
Continuation PCTUS2015014929 · Feb 6, 2015
Provisional Application 61936788 · Feb 6, 2014
Related Publication 20170088850A1 · Mar 30, 2017